Back
Travere Therapeutics Vs. Onto Innovation Industry Stock Comparison
Sell
45
TVTX
Travere Therapeutics
Last Price:
13.5100
Seasonality Move:
-12.44%
Buy
54
ONTO
Onto Innovation
Last Price:
197.90
Seasonality Move:
6.01%
Sell
45
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $13.4800. The Score for TVTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Onto Innovation (ONTO)
is a Buy
Is Onto Innovation a Buy, Sell or Hold?
- The current Onto Innovation [ONTO] share price is $197.82. The Score for ONTO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ONTO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $13.4800
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ONTO Stock Price Chart
What is Onto Innovation's stock price today?
-
The Onto Innovation share price today is $197.82
The current trend is relatively stagnant and ONTO is experiencing slight buying pressure.
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 79.38 | Buy |
| Chaikin Money Flow: | 1900513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.3004 - 11.4404) | Buy |
| Bollinger Bands (100): | (6.5341 - 9.9941) | Buy |
ONTO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.85 | Sell |
| Relative Strength Index (14 RSI): | 50.97 | Buy |
| Chaikin Money Flow: | 25185 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.5 - 211.56) | Sell |
| Bollinger Bands (100): | (188.95 - 226.55) | Sell |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.87 | Buy |
| 20-day SMA: | 10.17 | Buy |
| 50-day SMA: | 9.65 | Buy |
| 200-day SMA: | 8.17 | Buy |
| 8-day EMA: | 12.01 | Buy |
| 20-day EMA: | 10.75 | Buy |
| 50-day EMA: | 9.66 | Buy |
| 200-day EMA: | 9.2 | Buy |
ONTO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 187.64 | Buy |
| 20-day SMA: | 200.28 | Sell |
| 50-day SMA: | 200.51 | Sell |
| 200-day SMA: | 186.99 | Buy |
| 8-day EMA: | 192.22 | Buy |
| 20-day EMA: | 195.1 | Buy |
| 50-day EMA: | 199.41 | Sell |
| 200-day EMA: | 184.71 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.36 per share, a decrease this year of $2.18 per share, and an increase next year of $2.31 per share.
Onto Innovation Earnings Growth & ONTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.45 per share, an increase this year of $1.57 per share, and an increase next year of $1.33 per share.
Travere Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Onto Innovation Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||